News / blog
Filter articles:
News by product
Eyestar ↘
- VisionQuest Uses AI to Screen 40,000 Patients for Diabetic Retinopathy
- EyeStar Passes the 30,000-Patient Milestone for Diabetic Retinopathy Screening Using Artificial Intelligence
- The Challenges of Implementing a Nationwide Retina Screening Program
- VisionQuest Biomedical to Participate in Virtual Exhibit at the World Ophthalmology Congress 2020
- EyeStar Fulfills Need for Diabetic Retinopathy Screening in Bolivia
Aspire ↘
- Turning a Great Idea into a Successful Product: ASPIRE
- VisionQuest Receives $2M from NIH to Commercialize AI for Cerebral Malaria Diagnosis
- The Challenges of Implementing a Nationwide Retina Screening Program
- Through the Looking Glass: Using Artificial Intelligence to Recognize Cerebral Malaria in African Children
- VisionQuest Biomedical to Participate in Virtual Exhibit at the World Ophthalmology Congress 2020
- Glad to Say Yes: VisionQuest Supports Safe Clinical Research during the COVID-19 Pandemic
i-RxTherm ↘
- VQB Wins $1 Million to Commercialize System for Early Detection of DPN
- “Detecting Diabetic Peripheral Neuropathy Utilizing Thermoregulation Biomarkers of the Plantar Foot” Poster Presentation
- Screening Subjects for Diabetic Peripheral Neuropathy
- Early Diabetic Peripheral Neuropathy Detection with i-RxTherm
- VisionQuest Abstract on Diabetic Peripheral Neuropathy Accepted by ADA
- VisionQuest Biomedical and The University of New Mexico Combine Artificial Intelligence and Infrared Imaging to Diagnose Early Signs of Diabetic Foot
Would you like to know more about VisionQuest Biomedical?
Join our e-mail list to receive news relatedto Artificial Intelligence and VisionQuest Biomedical. Our company is growing, and we look forward to sharing updates with you!